BioAtla, Inc. (BCAB)
Data as of , from SEC Form 4 filings.
See up to 3 months of BCAB. The 7-day demo opens the 1M and 3M ranges and puts BCAB on your watchlist.
Start 7-day demoLatest BCAB insider trades
- Eric Sievers - OfficerTax withholding / forfeiture$226
Jay M. Phd Short - OfficerTax withholding / forfeiture$438- Christian Vasquez - Officer
About BioAtla, Inc. (BCAB)
BioAtla, Inc. files with the SEC under CIK 0001826892 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
BCAB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 3 | 464 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BCAB insider transactions (Form 4)
2926 Form 4 filings on record, the earliest from May 31, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 134 | $1.69 | $226 | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 259 | $1.69 | $438 | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 71 | $1.69 | $120 | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 175 | $0.17 | $30 | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 82 | $3.93 | $322 | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 639 | $0.17 | $107 | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 259 | $3.93 | $1K | |
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 360 | $0.17 | $61 | |
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 134 | $3.93 | $527 | |
| Eric Sievers - Officer | Grant or award | Common Stock | 240,000 footnote F1 | $0.00 | - | |
| ||||||
| Jay M. Phd Short - Officer | Grant or award | Common Stock | 430,000 footnote F1 | $0.00 | - | |
| ||||||
| Christian Vasquez - Officer | Grant or award | Common Stock | 240,000 footnote F1 | $0.00 | - | |
| ||||||
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 7,728 | $0.25 | $2K | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 1,802 | $0.25 | $445 | |
 Richard A. Waldron - Officer | Tax withholding / forfeiture | Common Stock | 2,729 | $0.25 | $674 | |
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 3,140 | $0.25 | $776 | |
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 2,729 | $0.90 | $2K | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 1,566 | $0.90 | $1K | |
| Richard A. Waldron - Officer | Tax withholding / forfeiture | Common Stock | 2,371 | $0.90 | $2K | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 6,347 | $0.90 | $6K | |
| Christian Vasquez - Officer | Tax withholding / forfeiture | Common Stock | 1,566 | $0.46 | $713 | |
| Eric Sievers - Officer | Tax withholding / forfeiture | Common Stock | 2,729 | $0.46 | $1K | |
| Richard A. Waldron - Officer | Tax withholding / forfeiture | Common Stock | 2,371 | $0.46 | $1K | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 6,347 | $0.46 | $3K | |
 Sylvia McBrinn | Grant or award | Common Stock | 23,500 | $0.00 | - | |
| Mary Ann Gray | Grant or award | Common Stock | 23,500 | $0.00 | - | |
 Lawrence Steinman | Grant or award | Common Stock | 23,500 | $0.00 | - | |
| Richard A. Waldron - Officer | Tax withholding / forfeiture | Common Stock | 2,371 | $0.41 | $970 | |
| Jay M. Phd Short - Officer | Tax withholding / forfeiture | Common Stock | 6,347 | $0.41 | $3K | |
BCAB insider trading FAQ
What is the latest insider trade for BCAB?
BioAtla, Inc. (BCAB) had 3 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for BCAB runs to 26 Form 4 filings, the earliest from 2025-05-31. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BCAB stock?
No insider purchases of BCAB were filed in the last 90 days.
How many insiders are selling BCAB stock?
No insider sales of BCAB were filed in the last 90 days.
Where can I see BCAB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BCAB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Eric Sievers view on EDGAR
- - Jay M. Phd Short view on EDGAR
- - Christian Vasquez view on EDGAR
- - Christian Vasquez view on EDGAR
- - Jay M. Phd Short view on EDGAR
- - Eric Sievers view on EDGAR
- - Eric Sievers view on EDGAR
- - Jay M. Phd Short view on EDGAR
- - Christian Vasquez view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BCAB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BCAB with a 7-day demo
- BCAB on your watchlist
- Every BCAB Form 4 filing on record
- Up to 3 months of BCAB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
